Serological response patterns to herpes virus type 2 early and late antigens in cervical carcinoma patients.
D000328:Adult; D000368:Aged; D000914:Antibodies, Viral / Q000096:biosynthesis*; D000956:Antigens, Viral / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D018139:Simplexvirus / Q000276:immunology*; D002583:Uterine Cervical Neoplasms / Q000276:immunology* / Q000382:microbiology / Q000473:pathology
D000914:Antibodies, Viral; D000956:Antigens, Viral